Philip T Cagle

Philip T Cagle

UNVERIFIED PROFILE

Are you Philip T Cagle?   Register this Author

Register author
Philip T Cagle

Philip T Cagle

Publications by authors named "Philip T Cagle"

Are you Philip T Cagle?   Register this Author

100Publications

1936Reads

17Profile Views

Interpathologist Diagnostic Agreement for Non-Small Cell Lung Carcinomas Using Current and Recent Classifications.

Arch Pathol Lab Med 2018 12 30;142(12):1537-1548. Epub 2018 Apr 30.

From the Department of Pathology & Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill (Drs Funkhouser Jr and Banks); Lineberger Comprehensive Cancer Center, UNC, Chapel Hill, North Carolina (Drs Funkhouser Jr, Hayes, Nikolaishvilli-Feinberg, and Grilley-Olson; Messrs Moore and Jo; and Ms Eeva); the Department of Medicine, UNC School of Medicine, Chapel Hill, North Carolina (Drs Hayes and Grilley-Olson); the Department of Computer Sciences, University of Wisconsin, Madison (Mr Funkhouser III); the Department of Biostatistics, UNC School of Public Health, Chapel Hill, North Carolina (Dr Fine); Medical Affairs, Ventana Medical Systems, Tucson, Arizona (Dr Banks); Unit of Pathology, Scientific Institute for Research and Health Care, San Giovanni Rotondo, Italy (Dr Graziano); the Department of Pathology, VA Medical Center, Durham, North Carolina (Dr Boswell); the Department of Medical Biosciences, Pathology, Umeå University Hospital, Umeå, Sweden (Dr Elmberger); the Department of Pathology, Kaiser-Permanente Hospital, Santa Clara, California (Dr Raparia); the Department of Pathology, Piedmont Medical Center, Rock Hill, South Carolina (Dr Hart); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Sholl); the Department of Pathology, Suburban Hospital, Bethesda, Maryland (Dr Nolan); the Department of Pathology, Mayo Clinic, Rochester, Minnesota (Dr Fritchie); the Department of Pathology, VA Medical Center, Dayton, Ohio (Dr Pouagare); the Department of Pathology, University of Texas Medical Branch, Galveston (Dr Allen); the Department of Pathology, Rex Hospital, Raleigh, North Carolina (Dr Volmar); the Department of Pathology, Medical College of Georgia, Augusta (Drs Biddinger and Kleven); the Department of Pathology, Flagstaff Medical Center, Flagstaff, Arizona (Dr Papez); the Department of Pathology, VA Medical Center, Charleston, South Carolina (Dr Spencer); the Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York (Dr Rekhtman); the Department of Pathology, Massachusetts General Hospital, Boston (Drs Mino-Kenudson and Hariri); and the Department of Pathology & Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Drs Driver and Cagle). Dr Allen is currently located at the Department of Pathology at University of Mississippi Medical Center, Jackson.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2017-0481-OADOI Listing
December 2018

Correlation Between Programmed Death Receptor-1 Expression in Tumor-Infiltrating Lymphocytes and Programmed Death Ligand-1 Expression in Non-Small Cell Lung Carcinoma.

Arch Pathol Lab Med 2018 11 12;142(11):1388-1393. Epub 2018 Feb 12.

From the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Drs Monroig-Bosque, Deavers, Bernicker, Cagle, and Miller); the Department of Pathology, Weill Cornell Medicine, New York, New York (Drs Monroig-Bosque, Bernicker, Cagle, and Miller); the Department of Pathology, University of Arkansas for Medical Science, Little Rock (Dr Driver); the Department of Medicine, University of Puerto Rico Medical Sciences Campus, San Juan (Dr Morales-Rosado); and Biocare Medical LLC, Pacheco, California (Dr Tacha).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2017-0516-OADOI Listing
November 2018

Immunohistochemistry of Pulmonary Biomarkers: A Perspective From Members of the Pulmonary Pathology Society.

Arch Pathol Lab Med 2018 Mar 7;142(3):408-419. Epub 2017 Jul 7.

From the Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands (Drs Thunnissen and Radonic); the Department of Pathology, The University of Texas Medical Branch, Galveston (Dr Allen); the Department of Pathology, Gustave Roussy, Villejuif, France (Dr Adam); the Department of Pathology, University of Colorado, Aurora (Dr Aisner); the Department of Pathology, Mount Sinai Medical Center, New York, New York (Dr Beasley); the Department of Pathology, Weill Cornell University Medical Center, New York, New York (Dr Borczuk); the Department of Pathology & Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Drs Cagle and Miller); the Department of Pathology, University of São Paulo, São Paulo, Brazil (Dr Capelozzi); the Department of Pathology, Royal Prince Alfred Hospital, Sydney, Australia (Dr Cooper); the Department of Pathology, Massachusetts General Hospital, Boston (Drs Hariri and Mino-Kenudson); the Department of Pathology, University Clinic Golnik, Golnik, Slovenia (Dr Kern); the Department of Pathology, INSERM U578, CHU A Michallon, Centre Léon Bérard, Lyon, Université Joseph Fourier INSERM U 823, Institut A. Bonniot, Grenoble, France (Dr Lantuejoul); the Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois (Dr Raparia); the Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (Dr Rekhtman); the Department of Pathology, The University Of Texas MD Anderson Cancer Center, Houston (Dr Roy-Chowdhuri); the Department of Pathology, St. Vincent's Pathology, Fitzroy, Australia (Ms Russell); the Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania (Dr Schneider); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Drs Sholl and Vivero); the Department of Pathology, University of Toronto, University Health Network, Toronto, Ontario, Canada (Dr Tsao); and the Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan (Dr Yatabe).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2017-0106-SADOI Listing
March 2018

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology.

Arch Pathol Lab Med 2018 Mar 22;142(3):321-346. Epub 2018 Jan 22.

From the Departments of Pathology (Drs Lindeman and Sholl) and Medicine (Dr Kwiatkowski), Brigham and Women's Hospital, Boston, Massachusetts; the Cancer Center (Dr Bernicker) and the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Dr Cagle); the Department of Pathology, University of Colorado School of Medicine, Denver (Dr Aisner); the Diagnostic and Molecular Pathology Laboratory (Dr Arcila) and the Molecular Diagnostics Service (Dr Ladanyi), Memorial Sloan Kettering Cancer Center, New York, New York; the Department of Pathology & Medicine, Pulmonary, Critical Care and Sleep Medicine, New York, New York (Dr Beasley); the Pathology and Laboratory Quality Center, College of American Pathologists, Northfield, Illinois (Mss Colasacco and Ventura); the Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania (Dr Dacic); the Department of Medicine and Pathology, University of Colorado, Denver (Dr Hirsch); the Department of Pathology, University of Aberdeen, Aberdeen, Scotland (Dr Kerr); the Department of Molecular Pathology, Roswell Park Cancer Institute, Buffalo, New York (Dr Nowak); the Clinical and Scientific Affairs Division, Association for Molecular Pathology, Bethesda, Maryland (Dr Temple-Smolkin); the Molecular Therapeutics and Biomarkers Laboratory, Peter Maccallum Cancer Center, Melbourne, Australia (Dr Solomon); the Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands (Dr Thunnissen); the Department of Laboratory Medicine and Pathobiology, Princess Margaret Cancer Center, Toronto, Ontario, Canada (Dr Tsao); Scientific Affairs, International Association for the Study of Lung Cancer, Aurora, Colorado (Dr Wynes); and the Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan (Dr Yatabe). Dr Souter is in private practice in Wellanport, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2017-0388-CPDOI Listing
March 2018

In Reply.

Arch Pathol Lab Med 2018 02 22;142(2):161. Epub 2017 Nov 22.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2017-0443-LEDOI Listing
February 2018

Hypersensitivity Pneumonitis A Perspective From Members of the Pulmonary Pathology Society.

Arch Pathol Lab Med 2018 Jan 14;142(1):120-126. Epub 2017 Jun 14.

From the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Drs Miller, Barrios, Cagle, and Ge); the Department of Pathology, University of Texas Medical Branch, Galveston (Dr Allen); the Department of Pathology, Mount Sinai Medical Center, New York, New York (Dr Beasley); the Department of Histopathology, Cork University Hospital, Cork, Ireland (Dr Burke); the Department of Pathology, University of São Paulo, São Paulo, Brazil (Dr Capelozzi); the Department of Pathology, Massachusetts General Hospital, Boston (Drs Hariri, Mark, and Mino-Kenudson); the Department of Pathology, Aberdeen University School of Medicine, Aberdeen, United Kingdom (Dr Kerr); the Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, Florida (Dr Khoor); the Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, Arizona (Drs Larsen and Smith); the Department of Pathology, National Defense Medical College, Tokorozawa, Japan (Dr Matsubara); the Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee (Dr Mehrad); the Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois (Dr Raparia); the Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota (Dr Roden); the Department of Pathology, St Vincent's Pathology, Fitzroy, Australia (Dr Russell); the Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania (Dr Schneider); and the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Sholl).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2017-0138-SADOI Listing
January 2018

Programmed Death Ligand-1 (PD-L1) Expression in Either Tumor Cells or Tumor-Infiltrating Immune Cells Correlates With Solid and High-Grade Lung Adenocarcinomas.

Arch Pathol Lab Med 2017 Nov 22;141(11):1529-1532. Epub 2017 Aug 22.

From the Departments of Pathology and Genomic Medicine (Drs Driver, R.A. Miller, T. Miller, Deavers, Gorman, Mody, Ge, Barrios, and Cagle), Medicine (Dr Bernicker), and Surgery (Dr Kim), Houston Methodist Hospital, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2017-0028-OADOI Listing
November 2017

Management of the Solitary Pulmonary Nodule.

Arch Pathol Lab Med 2017 Jul 2;141(7):927-931. Epub 2016 Sep 2.

From the Departments of Surgery, Division of Thoracic Surgery (Drs Chan, Gaur, and Kim); Pathology and Genomic Medicine (Drs Ge and Cagle); Interventional Pulmonology, Critical Care and Pulmonary Medicine (Drs Kopas and Santacruz); Radiology (Drs Gupta and Munden); Surgery, Weill Cornell Medical College (Drs Gaur and Kim); Pathology, Weill Cornell Medical College (Drs Ge and Cagle); and Radiology, Weill Cornell Medical College, Houston Methodist Hospital, Houston, Texas (Dr Munden).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2016-0307-RADOI Listing
July 2017

Diagnosis of Acute Cellular Rejection and Antibody-Mediated Rejection on Lung Transplant Biopsies: A Perspective From Members of the Pulmonary Pathology Society.

Arch Pathol Lab Med 2017 Mar 7;141(3):437-444. Epub 2016 Nov 7.

From the Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, Minnesota (Drs Roden, Aubry, and Yi); the Department of Pathology, University of Colorado, Denver (Dr Aisner); the Department of Pathology, University of Texas Medical Branch, Galveston (Dr Allen); the Department of Pathology and Genomic Medicine, Methodist Hospital, Houston, Texas (Drs Barrios, Cagle, Ge, and Miller); the Department of Pathology, Mount Sinai Health System, Icahn School of Medicine, New York, New York (Dr Beasley); the Department of Pathology, University of São Paolo, Brazil (Dr Capelozzi); the Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania (Dr Dacic); the Department of Pathology, Massachusetts General Hospital, and Harvard Medical School, Boston (Drs Hariri and Mino-Kenudson); Département de Biopathologie, Centre Léon Bérard, Lyon, Université Joseph Fourier INSERM U 823, Institut A. Bonniot, La Tronche, France (Dr Lantuejoul); the Department of Pathology, New York University Langone Medical Center, New York, New York (Dr Moreira); the Department of Pathology, Northwestern University, Chicago, Illinois (Dr Raparia); the Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (Dr Rekhtman); the Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (Drs Sholl and Vivero); the Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Scottsdale (Dr Smith); the Department of Pathology, University Health Network/Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada (Dr Tsao); and the Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan (Dr Yatabe).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2016-0459-SADOI Listing
March 2017

Naissance of the Archives of Pathology & Laboratory Medicine: A Critical Analysis of the January 1926, Volume 1 Issue.

Arch Pathol Lab Med 2016 10 11;140(10):1132-9. Epub 2016 Jul 11.

From the Department of Pathology and Laboratory Medicine, Emory University Hospital, Atlanta, Georgia (Dr Gal); and the Department of Pathology and Genomic Medicine, The Methodist Hospital, Houston, Texas (Dr Cagle).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2016-0250-SADOI Listing
October 2016

Liquid Biopsy in Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society.

Arch Pathol Lab Med 2016 Aug 19;140(8):825-9. Epub 2016 May 19.

From the Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (Drs Sholl and Vivero); the Department of Pathology, University of Colorado Cancer Center, Denver (Dr Aisner); the Department of Pathology, The University of Texas Medical Branch, Galveston (Dr Allen); the Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York (Dr Beasley); the Department of Pathology, Weill Cornell Medical College, New York, New York, and the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Dr Cagle); the Department of Pathology, University of Sao Paulo Medical School, Sao Paulo, Brazil (Dr Capelozzi); the Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania (Dr Dacic); the Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston (Drs Hariri and Mino-Kenudson); the Department of Pathology, Aberdeen University Medical School and Aberdeen Royal Infirmary, Foresterhill, Aberdeen, Scotland, United Kingdom (Dr Kerr); the Department of Biopathology, Centre Léon Bérard, Lyon, France, and J Fourier University-INSERM U 823-Institut A Bonniot, Grenoble, France (Dr Lantuejoul); the Department of Pathology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois (Dr Raparia); the Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (Dr Rekhtman); the Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston (Dr Roy-Chowdhuri); the Department of Pathology, VU Medical Center, Amsterdam, the Netherlands (Dr Thunnissen); the Department of Pathology, University Health Network/Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada (Dr Tsao); and the Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan (Dr Yatabe).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2016-0163-SADOI Listing
August 2016

First-Line Immune Therapy-Implications for Pathologists.

Arch Pathol Lab Med 2016 Aug;140(8):739-40

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2016-0904-EDDOI Listing
August 2016

Clinical Validation of a Novel Commercial Reverse Transcription-Quantitative Polymerase Chain Reaction Screening Assay for Detection of ALK Translocations and Amplifications in Non-Small Cell Lung Carcinomas.

Arch Pathol Lab Med 2016 Jul 24;140(7):690-3. Epub 2015 Nov 24.

From the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas. Dr Portier is now with Roche Tissue Diagnostics/Ventana Medical Systems (ROCHE Group), Tucson, Arizona.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2015-0419-OADOI Listing
July 2016

Folate Receptor α Expression Level Correlates With Histologic Grade in Lung Adenocarcinoma.

Arch Pathol Lab Med 2016 Jul 24;140(7):682-5. Epub 2015 Nov 24.

From the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Drs Driver, Barrios, Ge, Haque, and Cagle); and Biocare Medical LLC, Concord, California (Dr Tacha).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2015-0431-OADOI Listing
July 2016

PD-1/PD-L1, Only a Piece of the Puzzle.

Arch Pathol Lab Med 2016 Jul 11. Epub 2016 Jul 11.

From the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2016-0252-EDDOI Listing
July 2016

Forging into the Future: Archives Continues to Grow.

Authors:
Philip T Cagle

Arch Pathol Lab Med 2016 Jun;140(6):500

From the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2016-0902-EDDOI Listing
June 2016

Emerging Biomarkers in Personalized Therapy of Lung Cancer.

Adv Exp Med Biol 2016 ;890:25-36

Houston Methodist Hospital, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-319-24932-2_2DOI Listing
May 2016

Next-Generation Sequencing of a Cohort of Pulmonary Large Cell Carcinomas Reclassified by World Health Organization 2015 Criteria.

Arch Pathol Lab Med 2016 Apr 2;140(4):312-7. Epub 2015 Oct 2.

From the Departments of Pathology and Genomic Medicine (Drs Driver, Portier, Mody, Deavers, and Cagle); Medicine, Thoracic Medical Oncology (Dr Bernicker); Thoracic Surgery (Dr Kim); Radiation Oncology (Dr Teh); Interventional Pulmonology, Critical Care, and Pulmonary Medicine (Drs Santacruz and Kopas); Radiology (Dr Munden), Houston Methodist Hospital, Houston; and Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2015-0361-OADOI Listing
April 2016

Impact of Recent Developments in Lung Cancer on the Practice of Pathology.

Arch Pathol Lab Med 2016 Apr;140(4):322-5

From the Department of Pathology and Genomic Medicine (Drs Cagle, Ge, Haque, and Barrios).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2015-0535-SADOI Listing
April 2016

Biomarker Testing in Lung Carcinoma Cytology Specimens: A Perspective From Members of the Pulmonary Pathology Society.

Arch Pathol Lab Med 2016 Apr 15. Epub 2016 Apr 15.

From the Department of Pathology, University of Texas MD Anderson Cancer Center, Houston (Dr Roy-Chowdhuri); the Department of Pathology, University of Colorado Cancer Center, Denver (Dr Aisner); the Department of Pathology, University of Texas Medical Branch, Galveston (Dr Allen); the Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York (Dr Beasley); the Department of Pathology, Weill Cornell Medical College, New York (Drs Borczuk and Cagle); the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Dr Cagle); the Department of Pathology, University of Sao Paulo Medical School, Sao Paulo, Brazil (Dr Capelozzi); the Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania (Dr Dacic); the Department of Pathology, University Health Network, Princess Margaret Cancer Centre, and the University of Toronto, Toronto, Ontario, Canada (Drs da Cunha Santos and Tsao); the Department of Pathology, Massachusetts General Hospital, and Harvard Medical School, Boston (Drs Hariri and Mino-Kenudson); the Department of Pathology, Aberdeen University Medical School, and Aberdeen Royal Infirmary, Foresterhill, Aberdeen, Scotland, United Kingdom (Dr Kerr); the Department of Biopathology, Centre Léon Bérard, Lyon, and J Fourier University, Institut National de la Santé et de la Recherche Médicale-Institut Albert Bonniot, Grenoble, France (Dr Lantuejoul); the Department of Pathology, New York University, New York (Dr Moreira); the Department of Pathology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois (Dr Raparia); the Department of Pathology, Memorial Sloan Kettering Cancer Center, New York (Dr Rekhtman); the Department of Pathology, Brigham and Women's Hospital, and Harvard Medical School, Boston (Drs Sholl and Vivero); the Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands (Dr Thunnissen); and the Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan (Dr Yatabe).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2016-0091-SADOI Listing
April 2016

Challenges to Biomarker Testing for PD-1/PD-L1 Checkpoint Inhibitors for Lung Cancer.

Arch Pathol Lab Med 2015 Dec;139(12):1477-8

From the Department of Pathology and Genomic Medicine (Dr. Cagle) and Houston Methodist Cancer Center (Dr. Bernicker), Houston Methodist Hospital, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2015-0902-EDDOI Listing
December 2015

A New Immunotherapy Drug Creates a Watershed for the Surgical Pathologist's Role in Patient Care.

Arch Pathol Lab Med 2015 Nov;139(11):1329

From the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2015-0901-EDDOI Listing
November 2015

Template for Reporting Results of Biomarker Testing of Specimens From Patients With Tumors of the Central Nervous System.

Arch Pathol Lab Med 2015 Sep 2;139(9):1087-93. Epub 2015 Feb 2.

From the Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia (Dr Brat); the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Dr Cagle); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Dillon); the Department of Pathology, Indiana University Medical Center, Indianapolis (Dr Hattab); the Department of Pathology, Duke University Medical Center, Durham, North Carolina (Dr McLendon); Cancer Registry, Saint Agnes Hospital, Baltimore, Maryland (Ms Miller); and the Department of Oncology, Mayo Clinic, Rochester, Minnesota (Dr Buckner).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2014-0588-CPDOI Listing
September 2015

Cancer biomarker testing in the everyday practice of pathology.

Arch Pathol Lab Med 2015 May;139(5):583-4

From the Department of Pathology and Genomic Medicine (Dr Cagle, Ms Oommen, and Mr Kyle), the Office of Continuing Medical Education (Ms Stein), and the Office of Communications & External Relations, Institute for Academic Medicine (Ms Shemon), Houston Methodist Hospital, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2015-0025-EDDOI Listing
May 2015

The 2015 Physician Quality Reporting System reflects pathologists' role in lung cancer biomarker testing.

Arch Pathol Lab Med 2015 Apr 2;139(4):445. Epub 2015 Feb 2.

From the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Dr Cagle);

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2014-0619-EDDOI Listing
April 2015

A new ever-evolving paradigm.

Arch Pathol Lab Med 2015 Apr;139(4):446-7

From the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2014-0629-EDDOI Listing
April 2015

Peripheral lung adenocarcinomas with KRAS mutations are more likely to invade visceral pleura.

Arch Pathol Lab Med 2015 Feb 2;139(2):189-93. Epub 2014 Apr 2.

From the Departments of Pathology (Drs Raparia and Villa), and Pulmonary and Critical Care (Dr Raj), Northwestern University, Chicago, Illinois; and the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Dr Cagle).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2013-0759-OADOI Listing
February 2015

Utility of immunohistochemistry in the diagnosis of pleuropulmonary and mediastinal cancers: a review and update.

Arch Pathol Lab Med 2014 Dec;138(12):1611-28

From the Department of Laboratory Medicine, Geisinger Medical Center, Danville, Pennsylvania (Drs Zhang and Deng);

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2014-0092-RADOI Listing
December 2014

Correlation of EGFR mutation status with predominant histologic subtype of adenocarcinoma according to the new lung adenocarcinoma classification of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society.

Arch Pathol Lab Med 2014 Oct 26;138(10):1353-7. Epub 2014 Feb 26.

From the Department of Pathology (Drs Villa, Yeldandi, and Raparia), the Division of Medical Oncology, and Robert H. Lurie Comprehensive Cancer Center (Drs Johnson and Patel), the Division of Pulmonary, and Critical Care Medicine (Dr Raj); and the Division of Thoracic Surgery, and Robert H. Lurie Comprehensive Cancer Center (Dr DeCamp), Northwestern University Feinberg School of Medicine, Chicago, Illinois; and the Department of Pathology & Genomic Medicine, The Methodist Hospital, Houston, Texas (Dr Cagle).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2013-0376-OADOI Listing
October 2014

The presence of anti-HLA donor-specific antibodies in lung allograft recipients does not correlate with C4d immunofluorescence in transbronchial biopsy specimens.

Arch Pathol Lab Med 2014 Aug 28;138(8):1053-8. Epub 2013 Oct 28.

From the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Drs Roberts, Barrios, Cagle, Ge, Takei, Haque, Burns, Land, Dilioglou, and Bernard); and the Department of Pathology, Weill Cornell Medical College of Cornell University, Houston, Texas (Drs Barrios, Cagle, Ge, and Takei).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2013-0539-OADOI Listing
August 2014

Well-differentiated papillary mesothelioma with invasive foci.

Am J Surg Pathol 2014 Jul;38(7):990-8

*Department of Pathology, Vancouver General Hospital, Vancouver, BC, Canada †Department of Pathology, The University of Texas Medical Branch Galveston §Department of Pathology and Genomic Medicine, Houston Methodist Hospital **Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX ‡Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY ¶PhenoPath Laboratories, Seattle, WA ††Department of Laboratory Medicine and Pathology, Mayo Clinic in Arizona, Scottsdale, AZ ‡‡Department of Pathology, University of Virginia Health System, Charlottesville, VA ∥Department of Pathology, CHU Caen, Caen, France #Department of Clinical Pathology, Ospedale dell'Angelo Venezia, Mestre, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000200DOI Listing
July 2014

Whole slide images add value to journal article figures.

Arch Pathol Lab Med 2014 May;138(5):592

From the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2014-0042-EDDOI Listing
May 2014

EGFR mutations in US Hispanic versus non-Hispanic white patients with lung adenocarcinoma.

Arch Pathol Lab Med 2014 Apr 12;138(4):543-5. Epub 2013 Aug 12.

From the Department of Pathology (Dr Zhang), Molecular Diagnostics Laboratory (Dr Fan), and Department of Pathology (Dr Jagirdar), The University of Texas Health Science Center at San Antonio, and Laboratory Service, Audie L. Murphy Memorial Veterans Affairs Medical Center (Dr Tio), San Antonio; and Department of Pathology and Immunology, Baylor College of Medicine (Dr McQuitty), and Department of Pathology and Genomic Medicine, The Methodist Hospital (Drs Olsen and Cagle, Ms Hendrickson, and Mr Newton), Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2013-0311-OADOI Listing
April 2014

Lung adenocarcinoma biomarker incidence in Hispanic versus non-Hispanic white patients.

Arch Pathol Lab Med 2014 Mar 26;138(3):390-4. Epub 2013 Jun 26.

From the Department of Pathology, University of Texas Health Sciences Center, San Antonio (Drs Zhang and Jagirdar); the Department of Anatomic and Clinical Pathology, South Texas Veterans Health Care System, San Antonio (Dr Tio); and the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Drs McQuitty, Olsen, and Cagle and Ms Hendrickson). Dr McQuitty is now with the Department of Pathology and Immunology, Baylor College of Medicine, Houston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2013-0225-OADOI Listing
March 2014

Template for reporting results of biomarker testing of specimens from patients with non-small cell carcinoma of the lung.

Arch Pathol Lab Med 2014 Feb 28;138(2):171-4. Epub 2013 Jun 28.

From the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Dr Cagle); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Drs Sholl and Lindeman); the Department of Laboratory Medicine, Grand River Hospital, Kitchener, Ontario, Canada (Dr Divaris); the Department of Pathology, James A. Haley Veterans' Hospital, Tampa, Florida (Dr Foulis); the Cancer Information Program, Cancer Care Ontario, Ontario, Canada (Ms Lee); the Department of Medicine, Division of Oncology, Stanford Cancer Center, Stanford, California (Dr Neal); the Department of Pathology and Laboratory Medicine, NorthShore University HealthSystem, Evanston, Illinois (Dr Nowak); and the Department of Hematology-Oncology, Palo Alto Medical Foundation, Mountain View, California (Dr Yu). Dr Alsabeh is in private practice, Beverly Hills, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2013-0232-CPDOI Listing
February 2014

Verifying the role of surgical pathologists in the precision medicine of lung cancer.

Arch Pathol Lab Med 2013 Sep 31;137(9):1176-8. Epub 2012 Dec 31.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2012-0659-EDDOI Listing
September 2013

Tissue-preserving antibody cocktails to differentiate primary squamous cell carcinoma, adenocarcinoma, and small cell carcinoma of lung.

Arch Pathol Lab Med 2013 Sep 4;137(9):1274-81. Epub 2013 Jan 4.

Department of Pathology, University of Texas Health Science Center at San Antonio, 78229, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2012-0635-OADOI Listing
September 2013

Lung cancer biomarkers: present status and future developments.

Arch Pathol Lab Med 2013 Sep;137(9):1191-8

Department of Pathology and Genomic Medicine, The Methodist Hospital, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2013-0319-CRDOI Listing
September 2013

Pulmonary sclerosing papillary adenoma.

Pathol Int 2013 Jul;63(7):364-7

Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center at Tyler, Tyler, TX 75708, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pin.12075DOI Listing
July 2013

p16 Deletion in sarcomatoid tumors of the lung and pleura.

Arch Pathol Lab Med 2013 May;137(5):632-6

Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2012-0108-OADOI Listing
May 2013

Folate receptor in adenocarcinoma and squamous cell carcinoma of the lung: potential target for folate-linked therapeutic agents.

Arch Pathol Lab Med 2013 Feb 14;137(2):241-4. Epub 2012 Sep 14.

Department of Pathology and Genomic Medicine, The Methodist Hospital, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://www.archivesofpathology.org/doi/abs/10.5858/arpa.2012
Publisher Site
http://dx.doi.org/10.5858/arpa.2012-0176-OADOI Listing
February 2013

Pulmonary papillary adenoma: a case report and review of the literature.

J Bronchology Interv Pulmonol 2013 Jan;20(1):52-7

Department of Pathology, University of Massachusetts Medical School, Worcester, MA 01605, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/LBR.0b013e3182814cfdDOI Listing
January 2013

Evolving frontlines in the diagnosis and treatment of pulmonary diseases.

Authors:
Philip T Cagle

Arch Pathol Lab Med 2012 Dec;136(12):1476-7

From the Department of Pathology & Genomic Medicine, The Methodist Hospital, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2012-0518-EDDOI Listing
December 2012

Lung cancer genotype-based therapy and predictive biomarkers: present and future.

Arch Pathol Lab Med 2012 Dec;136(12):1482-91

Department of Pathology & Genomic Medicine, The Methodist Hospital, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2012-0508-RADOI Listing
December 2012

Differential diagnosis of lung carcinoma with coherent anti-Stokes Raman scattering imaging.

Arch Pathol Lab Med 2012 Dec;136(12):1502-10

Department of Systems Medicine and Bioengineering, The Methodist Hospital Research Institute, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2012-0238-SADOI Listing
December 2012

The transformation of pathology: proceedings of the Houston Lung Symposium.

Authors:
Philip T Cagle

Arch Pathol Lab Med 2012 Oct;136(10):1184-5

Department of Pathology and Genomic Medicine, Methodist Hospital, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2012-0382-EDDOI Listing
October 2012

Precision medicine for lung cancer: role of the surgical pathologist.

Arch Pathol Lab Med 2012 Oct;136(10):1186-9

Department of Pathology and Genomic Medicine, The Methodist Hospital, 6565 Fannin St., Main Building, Room 227, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://www.archivesofpathology.org/doi/abs/10.5858/arpa.2012
Publisher Site
http://dx.doi.org/10.5858/arpa.2012-0390-RADOI Listing
October 2012

Diffuse malignant mesothelioma.

Arch Pathol Lab Med 2012 Aug;136(8):882-8

Department of Pathology and Genomic Medicine, The Methodist Hospital, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2012-0142-CRDOI Listing
August 2012

Differential diagnosis of lung carcinoma with three-dimensional quantitative molecular vibrational imaging.

J Biomed Opt 2012 Jun;17(6):066017

Cornell University, The Methodist Hospital Research Institute, Weill Cornell Medical College, Department of Systems Medicine and Bioengineering, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://biomedicaloptics.spiedigitallibrary.org/article.aspx?
Publisher Site
http://dx.doi.org/10.1117/1.JBO.17.6.066017DOI Listing
June 2012

Advances in treatment of lung cancer with targeted therapy.

Arch Pathol Lab Med 2012 May;136(5):504-9

Department of Pathology & Genomic Medicine, The Methodist Hospital, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2011-0618-RADOI Listing
May 2012

On-the-spot lung cancer differential diagnosis by label-free, molecular vibrational imaging and knowledge-based classification.

J Biomed Opt 2011 Sep;16(9):096004

Weill Cornell Medical College, The Methodist Hospital Research Institute, Department of Systems Medicine and Bioengineering, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1117/1.3619294DOI Listing
September 2011

Increased levels of nuclear factor κB and Fos-related antigen 1 in lung tissues from patients with acute respiratory distress syndrome.

Arch Pathol Lab Med 2011 May;135(5):647-54

Department of Biochemistry, University of Texas Health Science Center, 11937 US Hwy 271, Tyler, TX 75708-3154, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1043/2009-0660-OAR1.1DOI Listing
May 2011

Pathology of the pleura: what the pulmonologists need to know.

Respirology 2011 Apr;16(3):430-8

Weill Medical College of Cornell University, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1440-1843.2011.01957.xDOI Listing
April 2011

Lung cancer and the future of pathology.

Arch Pathol Lab Med 2011 Mar;135(3):293-5

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1043/2011-0037-ED.1DOI Listing
March 2011

Revolution in lung cancer: new challenges for the surgical pathologist.

Arch Pathol Lab Med 2011 Jan;135(1):110-6

Department of Pathology and Laboratory Medicine, 6565 Fannin Street, The Methodist Hospital, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1043/2010-0567-RA.1DOI Listing
January 2011

Expression patterns of PAX5, c-Met, and paxillin in neuroendocrine tumors of the lung.

Arch Pathol Lab Med 2010 Nov;134(11):1702-5

Department of Pathology, University of Chicago Medical Center, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049158PMC
http://dx.doi.org/10.1043/2009-0664-OAR1.1DOI Listing
November 2010

Quantitative evaluation of protein expression as a function of tissue microarray core diameter: is a large (1.5 mm) core better than a small (0.6 mm) core?

Arch Pathol Lab Med 2010 Apr;134(4):613-9

Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06520-8023, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1043/1543-2165-134.4.613DOI Listing
April 2010

Lack of a major role of Staphylococcus aureus Panton-Valentine leukocidin in lower respiratory tract infection in nonhuman primates.

Am J Pathol 2010 Mar 21;176(3):1346-54. Epub 2010 Jan 21.

Center for Molecular and Translational Human Infectious Diseases Research, The Methodist Hospital Research Institute, the Methodist Hospital, and University of Houston, B490, 6565 Fannin Street, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2353/ajpath.2010.090960DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2832154PMC
March 2010

Lung Carcinoma Staging Problems.

Authors:
Philip T Cagle

Surg Pathol Clin 2010 Mar 7;3(1):61-9. Epub 2010 Jul 7.

Department of Pathology and Laboratory Medicine, Weil Medical College of Cornell University, 1300 York Avenue, New York, NY 10065, USA; Department of Pathology, The Methodist Hospital, Main Building, Room 227B, 6565 Fannin Street, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.path.2010.03.008DOI Listing
March 2010

Protocol for the examination of specimens from patients with primary non-small cell carcinoma, small cell carcinoma, or carcinoid tumor of the lung.

Arch Pathol Lab Med 2009 Oct;133(10):1552-9

Department of Pathology and Laboratory Medicine, Fletcher Allen Health Care, University of Vermont, Burlington, VT 05401-1473, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1043/1543-2165-133.10.1552DOI Listing
October 2009

Pulmonary epithelioid hemangioendothelioma mimicking mesothelioma.

Pathol Int 2008 Nov;58(11):730-4

Baylor College of Medicine and Methodist Hospital, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1440-1827.2008.02301.xDOI Listing
November 2008

Basic concepts of molecular pathology.

Arch Pathol Lab Med 2008 Oct;132(10):1551-6

Department of Pathology, The University of Texas Health Science Center at Tyler, TX 75708-3154, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1043/1543-2165(2008)132[1551:BCOMP]2.0.CO;2DOI Listing
October 2008

Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas.

Mod Pathol 2008 Jun 7;21(6):742-7. Epub 2008 Mar 7.

Division of Anatomic Pathology, Department of Pathology, University of Pittsburgh Medical Center, Presbyterian University Hospital, Pittsburgh, PA 15213, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/modpathol200845
Publisher Site
http://dx.doi.org/10.1038/modpathol.2008.45DOI Listing
June 2008

Significance of overexpression of alpha methylacyl-coenzyme A racemase in hepatocellular carcinoma.

J Exp Clin Cancer Res 2008 May 15;27. Epub 2008 May 15.

Department of Pathology, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1756-9966-27-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2438330PMC
May 2008

Pleuropulmonary desmoid tumors: immunohistochemical comparison with solitary fibrous tumors and assessment of beta-catenin and cyclin D1 expression.

Arch Pathol Lab Med 2006 Oct;130(10):1503-9

Department of Pathology and Laboratory Medicine, University of Texas Health Science Center at Houston Medical School, Houston, Tex, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1043/1543-2165(2006)130[1503:PDTICW]2.0.CO;2DOI Listing
October 2006

Interpreting the histopathology of chronic cough: a prospective, controlled, comparative study.

Chest 2006 Aug;130(2):362-70

Division of Pulmonary, Allergy, and Critical Care Medicine, University of Massachusetts Medical School, Worcester, MA 01655, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1378/chest.130.2.362DOI Listing
August 2006

Frozen section of lung specimens.

Arch Pathol Lab Med 2005 Dec;129(12):1602-9

Department of Pathology, The Methodist Hospital, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1043/1543-2165(2005)129[1602:FSOLS]2.0.CO;2DOI Listing
December 2005

The 100-year anniversary of the description of the frozen section procedure.

JAMA 2005 Dec;294(24):3135-7

Department of Pathology and Laboratory Medicine, Emory University Hospital, Room H171, 1364 Clifton Rd NE, Atlanta, GA 30322, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.294.24.3135DOI Listing
December 2005

Differential diagnosis of benign and malignant mesothelial proliferations on pleural biopsies.

Arch Pathol Lab Med 2005 Nov;129(11):1421-7

Department of Pathology, The Methodist Hospital, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1043/1543-2165(2005)129[1421:DDOBAM]2.0.CO;2DOI Listing
November 2005

Review and update of uncommon primary pleural tumors: a practical approach to diagnosis.

Arch Pathol Lab Med 2005 Nov;129(11):1428-43

Department of Pathology, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1043/1543-2165(2005)129[1428:RAUOUP]2.0.CO;2DOI Listing
November 2005

Prognostic significance of cyclooxygenase 2 expression in 259 cases of non-small cell lung cancer.

Arch Pathol Lab Med 2005 Sep;129(9):1113-7

Department of Pathology, Baylor College of Medicine, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1043/1543-2165(2005)129[1113:PSOCEI]2.0.CO;2DOI Listing
September 2005

Localized malignant mesothelioma.

Am J Surg Pathol 2005 Jul;29(7):866-73

Department of Pathology, Baylor College of Medicine, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.pas.0000165529.78945.dcDOI Listing
July 2005

The proposal to close the armed forces institute of pathology.

Authors:
Philip T Cagle

Arch Pathol Lab Med 2005 Jul;129(7):856-7

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1043/1543-2165(2005)129[856:TPTCTA]2.0.CO;2DOI Listing
July 2005

Silicone thorax due to a ruptured breast implant.

Chest 2005 May;127(5):1854-7

Department of Neurosurgery, The University of Texas School of Medicine, Houston, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1378/chest.127.5.1854DOI Listing
May 2005